These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 10486417

  • 1. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ.
    N Engl J Med; 1999 Sep 16; 341(12):857-65. PubMed ID: 10486417
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
    Pedersen OD, Brendorp B, Elming H, Pehrson S, Køber L, Torp-Pedersen C.
    Card Electrophysiol Rev; 2003 Sep 16; 7(3):220-4. PubMed ID: 14739717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
    Schmiegelow MD, Pedersen OD, Køber L, Seibæk M, Abildstrøm SZ, Torp-Pedersen C.
    BMC Cardiovasc Disord; 2011 May 14; 11():19. PubMed ID: 21569543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ, Markham A.
    Drugs; 1999 Dec 14; 58(6):1043-59. PubMed ID: 10651390
    [Abstract] [Full Text] [Related]

  • 9. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN.
    Card Electrophysiol Rev; 2003 Sep 14; 7(3):225-8. PubMed ID: 14739718
    [Abstract] [Full Text] [Related]

  • 10. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N, Sugrue AM, Padmanabhan D, Kella D, DeSimone CV, Kapa S, Asirvatham SJ, Lee HC, Ackerman MJ, Noseworthy PA.
    J Interv Card Electrophysiol; 2019 Mar 14; 54(2):189-196. PubMed ID: 30353374
    [Abstract] [Full Text] [Related]

  • 11. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
    Pedersen HS, Elming H, Seibaek M, Burchardt H, Brendorp B, Torp-Pedersen C, Køber L, DIAMOND Study Group.
    Am J Cardiol; 2007 Sep 01; 100(5):876-80. PubMed ID: 17719337
    [Abstract] [Full Text] [Related]

  • 12. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale.
    Nagra BS, Ledley GS, Kantharia BK.
    J Cardiovasc Pharmacol Ther; 2005 Sep 01; 10(3):191-5. PubMed ID: 16211208
    [Abstract] [Full Text] [Related]

  • 13. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
    Køber L, Bloch Thomsen PE, Møller M, Torp-Pedersen C, Carlsen J, Sandøe E, Egstrup K, Agner E, Videbaek J, Marchant B, Camm AJ, Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.
    Lancet; 2000 Dec 16; 356(9247):2052-8. PubMed ID: 11145491
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
    Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB.
    Circulation; 2000 Nov 07; 102(19):2385-90. PubMed ID: 11067793
    [Abstract] [Full Text] [Related]

  • 15. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.
    Møller M, Torp-Pedersen CT, Køber L.
    Congest Heart Fail; 2001 Nov 07; 7(3):146-150. PubMed ID: 11828153
    [Abstract] [Full Text] [Related]

  • 16. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 07; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 17. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L, Castro A, Dinelli M, Alboni P, Pappalardo A, Richiardi E, Santini M.
    Eur Heart J; 2000 Aug 07; 21(15):1265-73. PubMed ID: 10924317
    [Abstract] [Full Text] [Related]

  • 18. Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.
    Brendorp B, Elming H, Jun L, Køber L, Torp-Pedersen C, DIAMOND Study Group. Danish Investigations Of Arrhythmia and Mortality On Dofetilide.
    Eur J Heart Fail; 2002 Mar 07; 4(2):201-6. PubMed ID: 11959050
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD.
    Congenit Heart Dis; 2014 Mar 07; 9(3):221-7. PubMed ID: 23947935
    [Abstract] [Full Text] [Related]

  • 20. Dofetilide: a new class III antiarrhythmic agent.
    Al-Dashti R, Sami M.
    Can J Cardiol; 2001 Jan 07; 17(1):63-7. PubMed ID: 11173316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.